Millions of people across Africa and other low and middle-income countries, including Kenya, are set to access a powerful new HIV prevention option following a groundbreaking deal that will slash treatment costs.The Bill & Melinda Gates Foundation has partnered with Indian pharmaceutical company Hetero Labs to manufacture a generic version
